Status:
COMPLETED
Comparative Effect of Nigella Sativa and Conventional Management for OSMF
Lead Sponsor:
Ziauddin University
Conditions:
Oral Submucous Fibrosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Oral submucous fibrosis (OSMF) is a potentially malignant condition mainly characterized by inflammation and fibrosis of the submucosal tissues leading to marked rigidity and reduced opening of the ja...
Detailed Description
OSMF is a chronic insidious disorder of the oral cavity which has a great potential to turn malignant. The clinical manifestations of OSMF comprise of white, marble-like appearance of the oral mucosa ...
Eligibility Criteria
Inclusion
- Patients with the age of 18 years and above
- Patients clinically diagnosed with Oral submucous fibrosis
- Patients who have not received any treatment for Oral submucous fibrosis in the last three months.
- Patients who are willing to quit the habit of eating pan, gutka and areca nut
- Patients who are willing to attend the follow up visits
Exclusion
- Patients who are less than 18 years of age
- Patients who are already using pain medications, corticosteroids or immunosuppressive drugs in any other form
- Patients with a history of malignancy
- Patients presenting with oral lesions other than Oral submucous fibrosis (OSMF)
- Patients who are allergic to the drug material used in the clinical trial
- Patients who will not give consent
Key Trial Info
Start Date :
February 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04476420
Start Date
February 11 2021
End Date
September 30 2021
Last Update
March 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziauddin University, Clifton
Karachi, Sindh, Pakistan, 75600